Skip to main content
. 2012 Jul 11;2012(7):CD006534. doi: 10.1002/14651858.CD006534.pub2

Comparison 61. SE ‐ Nausea/vomiting.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Citalopram versus TCAs 6 1027 Odds Ratio (M‐H, Random, 95% CI) 1.78 [0.96, 3.30]
1.1 versus Amitriptyline 3 477 Odds Ratio (M‐H, Random, 95% CI) 2.44 [1.27, 4.66]
1.2 versus Imipramine 2 515 Odds Ratio (M‐H, Random, 95% CI) 0.98 [0.55, 1.73]
1.3 versus Nortriptyline 1 35 Odds Ratio (M‐H, Random, 95% CI) 7.11 [1.23, 40.98]
2 Citalopram versus heterocyclics 2 432 Odds Ratio (M‐H, Random, 95% CI) 2.82 [0.60, 13.23]
2.1 versus Maprotiline 1 96 Odds Ratio (M‐H, Random, 95% CI) 12.26 [0.66, 228.27]
2.2 versus Mianserin 1 336 Odds Ratio (M‐H, Random, 95% CI) 1.88 [0.89, 3.97]
3 Citalopram versus other SSRIs 12   Odds Ratio (M‐H, Random, 95% CI) Subtotals only
3.1 Versus Escitalopram 7 2055 Odds Ratio (M‐H, Random, 95% CI) 0.92 [0.49, 1.74]
3.2 Versus Fluoxetine 3 732 Odds Ratio (M‐H, Random, 95% CI) 1.46 [0.91, 2.35]
3.3 Versus Paroxetine 1 406 Odds Ratio (M‐H, Random, 95% CI) 1.15 [0.67, 1.95]
3.4 Versus Sertraline 1 42 Odds Ratio (M‐H, Random, 95% CI) 0.71 [0.14, 3.64]
4 Citalopram versus other conventional ADs 3   Odds Ratio (M‐H, Random, 95% CI) Subtotals only
4.1 versus Mirtazapine 1 270 Odds Ratio (M‐H, Random, 95% CI) 2.24 [1.12, 4.49]
4.2 versus Reboxetine 2 458 Odds Ratio (M‐H, Random, 95% CI) 3.46 [0.40, 29.92]